+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Heparin Market by Product Type (Low Molecular Weight Heparin, Ultra-Low Molecular Weight Heparin, Unfractionated Heparin), Route of Administration (IV Injection, Subcutaneous Injection), Application, End-User - Forecast 2024-2030- Product Image
Global Heparin Market by Product Type (Low Molecular Weight Heparin, Ultra-Low Molecular Weight Heparin, Unfractionated Heparin), Route of Administration (IV Injection, Subcutaneous Injection), Application, End-User - Forecast 2024-2030- Product Image
Sale

Global Heparin Market by Product Type (Low Molecular Weight Heparin, Ultra-Low Molecular Weight Heparin, Unfractionated Heparin), Route of Administration (IV Injection, Subcutaneous Injection), Application, End-User - Forecast 2024-2030

  • PDF Icon

    Report

  • 181 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5532742
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Heparin Market size was estimated at USD 7.85 billion in 2023, USD 8.69 billion in 2024, and is expected to grow at a CAGR of 11.19% to reach USD 16.49 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Heparin Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Heparin Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Heparin Market, highlighting leading vendors and their innovative profiles. These include Aspen Holdings, B. Braun Melsungen AG, Baxter International Inc., Bioiberica S.A.U., Bristol-Myers Squibb Co., Dr. Reddy’s Laboratories Ltd., Fresenius SE & Co. KGaA, GlaxoSmithKline plc, Hebei Changshan Biochemical Pharmaceutical Co., Ltd., Hospira Inc., LEO Pharma A/S, Novartis AG, Opocrin S.p.A., Pfizer Inc., and Sanofi S.A.

Market Segmentation & Coverage

This research report categorizes the Heparin Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product Type
    • Low Molecular Weight Heparin
    • Ultra-Low Molecular Weight Heparin
    • Unfractionated Heparin
  • Route of Administration
    • IV Injection
    • Subcutaneous Injection
  • Application
    • Clinical trials
    • Disease treatment
    • Medical devices
  • End-User
    • Blood & Stem Cell Bank
    • Hospitals
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

  1. What is the market size and forecast of the Heparin Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Heparin Market?
  3. What are the technology trends and regulatory frameworks in the Heparin Market?
  4. What is the market share of the leading vendors in the Heparin Market?
  5. Which modes and strategic moves are suitable for entering the Heparin Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Heparin Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growth in number of venous thromboembolism and cardiovascular disorders
5.1.1.2. High demand for anticoagulants
5.1.1.3. Rising incidences for deep vein thrombosis (DVT)
5.1.2. Restraints
5.1.2.1. Side effects associated with Heparin
5.1.3. Opportunities
5.1.3.1. Improved pharmaceutical focus on new drug development and development of synthetic heparin
5.1.3.2. Increasing health expenditure and awareness among patients
5.1.4. Challenges
5.1.4.1. Porcine availability issues
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Heparin Market, by Product Type
6.1. Introduction
6.2. Low Molecular Weight Heparin
6.3. Ultra-Low Molecular Weight Heparin
6.4. Unfractionated Heparin
7. Heparin Market, by Route of Administration
7.1. Introduction
7.2. IV Injection
7.3. Subcutaneous Injection
8. Heparin Market, by Application
8.1. Introduction
8.2. Clinical trials
8.3. Disease treatment
8.4. Medical devices
9. Heparin Market, by End-User
9.1. Introduction
9.2. Blood & Stem Cell Bank
9.3. Hospitals
10. Americas Heparin Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Heparin Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Heparin Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. Aspen Holdings
14.1.2. B. Braun Melsungen AG
14.1.3. Baxter International Inc.
14.1.4. Bioiberica S.A.U.
14.1.5. Bristol-Myers Squibb Co.
14.1.6. Dr. Reddy’s Laboratories Ltd.
14.1.7. Fresenius SE & Co. KGaA
14.1.8. GlaxoSmithKline plc
14.1.9. Hebei Changshan Biochemical Pharmaceutical Co., Ltd.
14.1.10. Hospira Inc.
14.1.11. LEO Pharma A/S
14.1.12. Novartis AG
14.1.13. Opocrin S.p.A.
14.1.14. Pfizer Inc.
14.1.15. Sanofi S.A.
14.2. Key Product Portfolio
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
List of Figures
FIGURE 1. HEPARIN MARKET RESEARCH PROCESS
FIGURE 2. HEPARIN MARKET SIZE, 2023 VS 2030
FIGURE 3. HEPARIN MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. HEPARIN MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. HEPARIN MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. HEPARIN MARKET DYNAMICS
FIGURE 7. HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
FIGURE 8. HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
FIGURE 10. HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. HEPARIN MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 12. HEPARIN MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. HEPARIN MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 14. HEPARIN MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS HEPARIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS HEPARIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES HEPARIN MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES HEPARIN MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC HEPARIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC HEPARIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA HEPARIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA HEPARIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. HEPARIN MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 24. HEPARIN MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. HEPARIN MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. HEPARIN MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL HEPARIN MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 6. HEPARIN MARKET SIZE, BY LOW MOLECULAR WEIGHT HEPARIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. HEPARIN MARKET SIZE, BY ULTRA-LOW MOLECULAR WEIGHT HEPARIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. HEPARIN MARKET SIZE, BY UNFRACTIONATED HEPARIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 10. HEPARIN MARKET SIZE, BY IV INJECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. HEPARIN MARKET SIZE, BY SUBCUTANEOUS INJECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 13. HEPARIN MARKET SIZE, BY CLINICAL TRIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. HEPARIN MARKET SIZE, BY DISEASE TREATMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. HEPARIN MARKET SIZE, BY MEDICAL DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 17. HEPARIN MARKET SIZE, BY BLOOD & STEM CELL BANK, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. HEPARIN MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. AMERICAS HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS HEPARIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 24. ARGENTINA HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 25. ARGENTINA HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 26. ARGENTINA HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 27. ARGENTINA HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 28. BRAZIL HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 29. BRAZIL HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 30. BRAZIL HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 31. BRAZIL HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 32. CANADA HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 33. CANADA HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 34. CANADA HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 35. CANADA HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 36. MEXICO HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 37. MEXICO HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 38. MEXICO HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 39. MEXICO HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 40. UNITED STATES HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 41. UNITED STATES HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES HEPARIN MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 45. ASIA-PACIFIC HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 46. ASIA-PACIFIC HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 47. ASIA-PACIFIC HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 48. ASIA-PACIFIC HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 49. ASIA-PACIFIC HEPARIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 50. AUSTRALIA HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 51. AUSTRALIA HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 52. AUSTRALIA HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 53. AUSTRALIA HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 54. CHINA HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 55. CHINA HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 56. CHINA HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 57. CHINA HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 58. INDIA HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 59. INDIA HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 60. INDIA HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 61. INDIA HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 62. INDONESIA HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 63. INDONESIA HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 64. INDONESIA HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 65. INDONESIA HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 66. JAPAN HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 67. JAPAN HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 68. JAPAN HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 69. JAPAN HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 70. MALAYSIA HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 71. MALAYSIA HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 72. MALAYSIA HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 73. MALAYSIA HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 74. PHILIPPINES HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 75. PHILIPPINES HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 76. PHILIPPINES HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 77. PHILIPPINES HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 78. SINGAPORE HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 79. SINGAPORE HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 80. SINGAPORE HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 81. SINGAPORE HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 82. SOUTH KOREA HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 83. SOUTH KOREA HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 84. SOUTH KOREA HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 85. SOUTH KOREA HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 86. TAIWAN HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 87. TAIWAN HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 88. TAIWAN HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 89. TAIWAN HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 90. THAILAND HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 91. THAILAND HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 92. THAILAND HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 93. THAILAND HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 94. VIETNAM HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 95. VIETNAM HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 96. VIETNAM HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 97. VIETNAM HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 98. EUROPE, MIDDLE EAST & AFRICA HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA HEPARIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 103. DENMARK HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 104. DENMARK HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 105. DENMARK HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 106. DENMARK HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 107. EGYPT HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 108. EGYPT HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 109. EGYPT HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 110. EGYPT HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 111. FINLAND HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 112. FINLAND HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 113. FINLAND HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 114. FINLAND HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 115. FRANCE HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 116. FRANCE HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 117. FRANCE HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 118. FRANCE HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 119. GERMANY HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 120. GERMANY HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 121. GERMANY HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 122. GERMANY HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 123. ISRAEL HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 124. ISRAEL HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 125. ISRAEL HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 126. ISRAEL HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 127. ITALY HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 128. ITALY HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 129. ITALY HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 130. ITALY HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 131. NETHERLANDS HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 132. NETHERLANDS HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 133. NETHERLANDS HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 134. NETHERLANDS HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 135. NIGERIA HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 136. NIGERIA HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 137. NIGERIA HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 138. NIGERIA HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 139. NORWAY HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 140. NORWAY HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 141. NORWAY HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 142. NORWAY HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 143. POLAND HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 144. POLAND HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 145. POLAND HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 146. POLAND HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 147. QATAR HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 148. QATAR HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 149. QATAR HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 150. QATAR HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 151. RUSSIA HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 152. RUSSIA HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 153. RUSSIA HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 154. RUSSIA HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 155. SAUDI ARABIA HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 156. SAUDI ARABIA HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 157. SAUDI ARABIA HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 158. SAUDI ARABIA HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 159. SOUTH AFRICA HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 160. SOUTH AFRICA HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 161. SOUTH AFRICA HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 162. SOUTH AFRICA HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 163. SPAIN HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 164. SPAIN HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 165. SPAIN HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 166. SPAIN HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 167. SWEDEN HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 168. SWEDEN HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 169. SWEDEN HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 170. SWEDEN HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 171. SWITZERLAND HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 172. SWITZERLAND HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 173. SWITZERLAND HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 174. SWITZERLAND HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 175. TURKEY HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 176. TURKEY HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 177. TURKEY HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 178. TURKEY HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 179. UNITED ARAB EMIRATES HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 180. UNITED ARAB EMIRATES HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 181. UNITED ARAB EMIRATES HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 182. UNITED ARAB EMIRATES HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 183. UNITED KINGDOM HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 184. UNITED KINGDOM HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 186. UNITED KINGDOM HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 187. HEPARIN MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 188. HEPARIN MARKET SHARE, BY KEY PLAYER, 2023
TABLE 189. HEPARIN MARKET LICENSE & PRICING

Companies Mentioned

  • Aspen Holdings
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Bioiberica S.A.U.
  • Bristol-Myers Squibb Co.
  • Dr. Reddy’s Laboratories Ltd.
  • Fresenius SE & Co. KGaA
  • GlaxoSmithKline plc
  • Hebei Changshan Biochemical Pharmaceutical Co., Ltd.
  • Hospira Inc.
  • LEO Pharma A/S
  • Novartis AG
  • Opocrin S.p.A.
  • Pfizer Inc.
  • Sanofi S.A.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages181
PublishedMarch 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 8.69 Billion
Forecasted Market Value ( USD ) by 2030 $ 16.49 Billion
Compound Annual Growth Rate11.1%
Regions CoveredGlobal
No. of Companies Mentioned15

Related Topics

Related Reports

Global Heparin Market Size, Share & Trends Analysis Report by Type, Route of Administration, Application, End-use (Outpatient, Inpatient), Source, Region, and Segment Forecasts, 2024-2030 - Product Image

Global Heparin Market Size, Share & Trends Analysis Report by Type, Route of Administration, Application, End-use (Outpatient, Inpatient), Source, Region, and Segment Forecasts, 2024-2030

  • Report
  • 111 Pages
  • Global
From
Heparin Global Market Report 2024 - Product Image

Heparin Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Heparin Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 - Product Image

Heparin Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028

  • Report
  • 185 Pages
  • Global
From
Heparin Market Report by Product, Source, Mode of Administration, Application, End-User, Distribution Channel, and Region 2024-2032 - Product Image

Heparin Market Report by Product, Source, Mode of Administration, Application, End-User, Distribution Channel, and Region 2024-2032

  • Report
  • 148 Pages
  • Global
From
Heparin Market Forecasts from 2023 to 2028 - Product Image

Heparin Market Forecasts from 2023 to 2028

  • Report
  • 140 Pages
  • Global
From

About the Heparin Market

Heparin is a type of anticoagulant drug used in the treatment of cardiovascular diseases. It is a naturally occurring anticoagulant, derived from the mucous membranes of animals, and is used to prevent the formation of blood clots. It is commonly used in the treatment of deep vein thrombosis, pulmonary embolism, and atrial fibrillation. It is also used to prevent clotting during hemodialysis and to prevent clotting during surgery. Heparin is available in both injectable and oral forms, and is typically administered in a hospital setting. It is also available in a variety of formulations, including low molecular weight heparin, unfractionated heparin, and fondaparinux. The cost of heparin varies depending on the formulation and the dosage. Heparin is a widely used anticoagulant in the cardiovascular drugs market. It is used in a variety of cardiovascular conditions, and is an important part of the treatment of many cardiovascular diseases. Some companies in the heparin market include Sanofi, Pfizer, Bristol-Myers Squibb, and GlaxoSmithKline. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.